Publications by authors named "Oren Barboy"

Claim this Profile
D
Distinct Cellular and Molecular Patterns in Pretreatment Peripheral Blood Are Associated with CAR T-cell Outcomes in Diffuse Large B-cell Lymphoma.
Anna Gurevich-Shapiro, Pascale Zwicky, Eitan Winter, Mor Zada, Noam Shapira, Oren Barboy

Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness.
Sandra Camargo, Ori Moskowitz, Amir Giladi, Maiia Levinson, Roi Balaban, Oren Barboy

Nat Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.
Oren Barboy, Akhiad Bercovich, Hanjie Li, Yaniv Eyal-Lubling, Adam Yalin

Nat Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific dendritic-T cell engager potentiates anti-tumor immunity.
Yuval Shapir Itai, Oren Barboy, Ran Salomon, Akhiad Bercovich, Ken Xie

Cell· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Synergy: Optimizing CAR T Development and Personalizing Patient Care Using Single-Cell Technologies.
Oren Barboy, Yonatan Katzenelenbogen, Rotem Shalita, Ido Amit

Cancer Discov· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcriptional and regulatory identity of erythropoietin producing cells.
Bjørt K Kragesteen, Amir Giladi, Eyal David, Shahar Halevi, Laufey Geirsdóttir, Oren Barboy

Nat Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.
Ido Yofe, Tomer Landsberger, Adam Yalin, Isabelle Solomon, Cristobal Costoya, Oren Barboy

Nat Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.
Ido Yofe, Tomer Landsberger, Adam Yalin, Isabelle Solomon, Cristobal Costoya, Oren Barboy

Nat Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.
Chamutal Gur, Shuang-Yin Wang, Fadi Sheban, Mor Zada, Baoguo Li, Oren Barboy

Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interaction of CD4 helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response.
Merav Cohen, Amir Giladi, Oren Barboy, Pauline Hamon, Baoguo Li

Nat Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: XCR1 type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori, Dominik Pfister, Michal Safran, Oren Barboy

Nat Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XCR1 type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori, Dominik Pfister, Michal Safran, Oren Barboy

Nat Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis